Cutting edge Finometer equipment introduced

Posted:
7
July 2004

[Finometer]

The newest addition to our sophisticated range of technologies is the highly accurate and reliable blood pressure measuring device, the Finometer.Our Research Director, Dr Radivoj Arezina, MD MSc, commented “Our new Finometer compliments our expanding range of highly sophisticated equipment. The device not only allows continuous measurement of blood pressure in a particularly thorough and scientific manner, but also stores information and converts it into a range of user friendly formats to enable accurate analysis of the waveform. The impact this type of technology has on clinical studies is considerable; we now provide rapid, wide ranging and definitive analysis on the effect of drugs on arterial blood pressure.”The instrument includes Beatscope PC-based software and allows almost complete non-invasive characterisation of the arterial circulation and its beat-to-beat variability in pressure and flow. The new device is able to measure systolic, diastolic and true mean arterial pressure, heart rate, interbeat interval, left ventricular ejection time, stroke volume, cardiac output, systemic peripheral resistance and a time-tension index.

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more